GE HealthCare Secures FDA Clearance for AI-Powered Radiation Therapy Software

Key Facts

1GE HealthCare received FDA 510(k) clearance for its AI-powered MIM Contour ProtégéAI+ 2.0 software.

In a move reflecting the accelerating adoption of smart technologies in the medical sector, GE HealthCare has secured FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software. This AI-powered solution aims to automate manual contouring in radiation therapy planning, significantly enhancing clinical efficiency. The integration is designed to reduce clinician workload and improve the personalization of patient care through automated workflows.

This regulatory milestone arrives as major health-tech peers like Siemens Healthineers and Philips intensify competition to integrate AI into imaging and therapy platforms. Per market data, the AI medical software sector is seeing sustained growth as hospitals seek to lower operational costs, with recent peer earnings reports highlighting increased demand for solutions that minimize human intervention in routine tasks.

Regarding market performance, GEHC stood at $64.76 (at close June 15, 2026), with a daily trading range between $64.64 and $66.44. Traders are currently monitoring support levels near the June 15 low, while the market awaits the upcoming Michigan Consumer Sentiment data, which could influence broader healthcare sector sentiment.